Takeda Pharmaceuticals announces Japan MAP failure November 22 2011 X LinkedIn Email Show more sharing options Copy Link URLCopied! Print X LinkedIn Email Takeda Pharmaceuticals has announced that its mutual agreement procedure (MAP) with the National Tax Agency in Japan did not result in an agreement with the US. Unlock this content. The content you are trying to view is exclusive to our subscribers. To unlock this content: Take a Free Trial or Login